Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 9667
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241831(CHEMBL4062273 | US10899756, Compound U | US1062611...)
Affinity DataIC50: 0.0440nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241831(CHEMBL4062273 | US10899756, Compound U | US1062611...)
Affinity DataIC50: 0.0560nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241840(CHEMBL4072903 | US10899756, Compound K)
Affinity DataIC50: 0.0590nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480487(US10899756, Compound D | US10626113, Compound D)
Affinity DataIC50: 0.0700nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241832(CHEMBL4083986 | US10899756, Compound C | US1062611...)
Affinity DataIC50: 0.200nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241842(CHEMBL4064315 | US10899756, Compound M)
Affinity DataIC50: 0.290nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241835(CHEMBL4092717 | US10899756, Compound AC)
Affinity DataIC50: 0.320nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50242157(CHEMBL4070894 | US10899756, Compound B | US1062611...)
Affinity DataIC50: 1nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241834(CHEMBL4065036 | US10899756, Compound R | US1062611...)
Affinity DataIC50: 1.5nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241837(CHEMBL4102913 | US10899756, Compound G | US1062611...)
Affinity DataIC50: 1.55nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241843(CHEMBL4102250 | US10899756, Compound N)
Affinity DataIC50: 1.70nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480506(US10899756, Compound AB)
Affinity DataIC50: 3.30nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241841(CHEMBL4092040 | US10899756, Compound L)
Affinity DataIC50: 3.80nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480489(US10899756, Compound F | US10626113, Compound F)
Affinity DataIC50: 5.40nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480504(US10899756, Compound W | US10626113, Compound O)
Affinity DataIC50: 10.6nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50242154(CHEMBL4099788 | US10899756, Compound A | US1062611...)
Affinity DataIC50: 21.6nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480503(US10899756, Compound V | US10626113, Compound N)
Affinity DataIC50: 26.9nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetRod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha(Human)
Columbia University

US Patent
LigandPNGBDBM480487(US10899756, Compound D | US10626113, Compound D)
Affinity DataIC50: 30nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetRod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha(Human)
Columbia University

US Patent
LigandPNGBDBM50241831(CHEMBL4062273 | US10899756, Compound U | US1062611...)
Affinity DataIC50: 30.1nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480488(US10899756, Compound E | US10626113, Compound E)
Affinity DataIC50: 43.8nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50242155(CHEMBL4100445 | US10899756, Compound AA)
Affinity DataIC50: 57nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50242158(CHEMBL4084285 | US10899756, Compound 0)
Affinity DataIC50: 64nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetRod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha(Human)
Columbia University

US Patent
LigandPNGBDBM50241837(CHEMBL4102913 | US10899756, Compound G | US1062611...)
Affinity DataIC50: 100nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50242156(CHEMBL4096417 | US10899756, Compound P)
Affinity DataIC50: 333nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM50241833(CHEMBL4073617 | US10899756, Compound Q | US1062611...)
Affinity DataIC50: 337nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480501(US10899756, Compound T | US10626113, Compound L)
Affinity DataIC50: 425nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Columbia University

US Patent
LigandPNGBDBM480500(US10899756, Compound S | US10626113, Compound K)
Affinity DataIC50: 593nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetRod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha(Human)
Columbia University

US Patent
LigandPNGBDBM480488(US10899756, Compound E | US10626113, Compound E)
Affinity DataIC50: 6.62E+3nMAssay Description:A series of dilutions of the test compounds were prepared with 10% DMSO in assay buffer and 5 μl of the dilution was added to a 50 μl react...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent